Wael is a highly skilled and accomplished professional with over 12 years of experience in the field of genetics and healthcare.

He earned his Master’s degree in Genetics & Biotechnology from the prestigious Institut Superieur de Biotechnologie de Monastir, spanning the years 2007 to 2010.

He brings a wealth of expertise to the industry, showcasing a diverse skill set that encompasses various crucial areas. His expertise encompasses not only specific disease areas but also broader aspects of the healthcare landscape, including Health Economics, Pricing, HTA and Market Access Strategy.

This multifaceted understanding positions Wael as a valuable asset, capable of addressing challenges at both micro and macro levels within the pharmaceutical and healthcare sectors.